Short communicationPublished 30 Mar 2022

Chronic pulmonary aspergillosis and diagnostic challenge

Authors: Ritu Singhal

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chronic Pulmonary Aspergillosis (CPA) is pulmonary disease estimated to affect 3 million people worldwide making it an under-recognized, but significant health problem world-wide, which however confers significant morbidity and mortality. The disease is caused by Aspergillus species, which can reach respiratory tract by air-borne transmission. Any form of lung injury or illness is predisposing factor for development of CPA, among which most common cause is pulmonary tuberculosis. Such pulmonary injury affects local host defenses enabling Aspergillus conidia to germinate within lung. It is crucial to diagnose CPA timely and appropriately to ensure relevant treatment considering similarity of CPA to many other diseases. Diagnosis of CPA is based on well-established diagnostic criteria , which requires thoracic imaging, direct microbiological evidence of Aspergillus infection or an immune response to Aspergillus spp . New laboratory diagnostics have been developed specifically for diagnosing CPA, which need to be evaluated specifically for CPA and utilized for diagnosis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Molecular Pathology : Open Access.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Molecular Pathology : Open Access
  • SubjectGenetics & Molecular Biology
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Ritu Singhal”